Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

@article{Naderi2012AdherenceTD,
  title={Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.},
  author={Sayed H Naderi and Jonathan P. Bestwick and David S Wald},
  journal={The American journal of medicine},
  year={2012},
  volume={125 9},
  pages={882-7.e1}
}
OBJECTIVE Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary heart disease, but the full preventive effect is only realized if treatment continues indefinitely. Our objective was to provide a summary estimate of adherence to drugs that prevent coronary heart disease, according to drug class and use in people who have had a myocardial infarction (secondary prevention) and people who have not (primary… CONTINUE READING